• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medpace Acquires European CRO, Has Big Plans for Growth

Medpace Acquires European CRO, Has Big Plans for Growth

January 21, 2010
CenterWatch Staff

Cincinnati-based contract research organization (CRO) Medpace acquired European CRO Medical Consulting Dr. Schlichtiger for an undisclosed sum.

Based in Munich, Germany, Medical Consulting provides drug development services with a focus on regulatory consulting and pharmacovigilance. The company was founded in 1989 by Ursula Schlichtiger, M.D., now the company’s general manager.

Schlichtiger will join the Medpace team as managing director and senior director of medical and regulatory affairs.

Medpace plans to complete the integration of Medical Consulting later this year.

According to Medpace, the acquisition will strengthen the CRO’s European presence by providing centralized European hubs for regulatory submissions and approvals as well as drug safety management and reporting.

Medpace’s European headquarters is based in The Netherlands with regional offices scattered through Europe. The CRO also has Asian headquarters in Singapore and regional offices in Asia, Australia, South Africa and the Americas.

U.S. investigative sites rated Medpace the top CRO to work with in the 2009 CenterWatch Site Survey. The company has 1000 employees worldwide but plans to add another 760 by 2014. To accommodate this growth, Medpace began construction earlier this month on a new 132,000-square-foot corporate headquarters  in Cincinnati.

Upcoming Events

  • 15Apr

    Five Telltale Signs You’re Ready for an Electronic TMF System

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Clinical-Trial-Brainstorming

    FDA, Industry Tackle Problem of Including Older Adults in Trials

  • ClinicalTrialNetwork-360x240.png

    National Community-Based Research Network Would Improve Reach of Trials

  • Bottleneck-360x240.png

    Sites Face Trials Bottleneck After Pandemic, But Also Opportunities

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Genetic Research and IBC Oversight Requirements

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing